Jamie N Anastas

6PUBLICATIONS
98CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2026
Elongin B orchestrates chromatin and transcriptional programs in H3K27M-mutant diffuse midline glioma.

|Apr 17, 2026
H3 dopaminylation and CaMKII modulate diffuse midline glioma response to CDK9 inhibition.

|Feb 06, 2026
SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma.

Rosemary U Richard, Caitlin Bagnetto, Rebecca L Murdaugh

|May 21, 2024
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Frank Y Lin, Austin Stuckert, Candise Tat

|Sep 11, 2023
SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells.

Linda Zhang, Joanne I Hsu, Etienne D Braekeleer

|Oct 28, 2022
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma.

Eshini Panditharatna, Joana G Marques, Tingjian Wang

Pageof 1

Frequent Collaborators

3 joint publications

Rebecca L Murdaugh

2 joint publications

Brittany R Eberl

2 joint publications

Akdes Serin-Harmanci

2 joint publications

Alan L Jiao